SLC6A3 and Parkinson disease: We detected the expression level of DAT in the striatum, and the results showed that BAP31 deletion could exacerbate the significant reduction in DAT levels in the striatum of PD mice injected with MPTP compared with BAP31fl/fl mice (Figure 4d).